CONTENTS
Introduction to Inflammation in Cardiovascular Disease
Innate Immune Cell Heterogeneity
Monocytes
Macrophages
Dendritic Cells
Innate Immune Pathogenesis of Heart Failure
Innate Immune Response to Injury
DAMPs/PAMPs
PRRs
Innate Immune System in Heart Failure Etiologies
Atherosclerosis
Hypertension
Myocardial Ischemia
Myocarditis
Arrhythmias
Cardio-Oncology
Heart Transplant
Conclusion and Future Directions
Bibliography
INTRODUCTION TO INFLAMMATION IN CARDIOVASCULAR DISEASE
The immune system has been implicated in many cardiac disease pathologies, ranging from heart failure to coronary artery disease to myocarditis. In these disease states, markers of systemic inflammation are elevated and are associated with adverse outcomes. However, the cellular sources, mechanisms of activation, and temporal implications of the inflammatory cascade are poorly understood. Early clinical trials broadly targeting inflammation yielded underwhelming results, dampening enthusiasm for further drug development. Recently, there has been renewed interest in the field fueled by new studies identifying surprising heterogeneity within the innate immune cell repertoire. As such, we now understand that diverse populations of innate immune cells reside within the healthy as well as the diseased heart, each with unique origins, dynamics, functions, and potential therapeutic implications.
There are 12 times as many immune cells in the heart compared to skeletal muscle [1]. The immune response is divided into (1) the innate and (2) the humoral/adaptive responses. The innate immune system responds to molecular patterns found in pathogens (pathogen-associated molecular patterns, PAMPs) and to host proteins released following tissue injury (danger-associated molecular patterns, DAMPs). Following activation, innate immune cells express a diverse array of chemokines, cytokines, growth factors, lipid mediators, and oxidative products, with wide-ranging effects on tissue repair, inflammation, and adaptive immunity. During steady state, innate immunity restricts maladaptive activation of the adaptive immune system, but during disease, it activates and targets the adaptive response to the insult. In this chapter, we will focus on the role of the innate immune response and implications for health and cardiovascular disease.
INNATE IMMUNE CELL HETEROGENEITY
The innate immune system has a myriad of cells that can be distinguished by their ontological origin. Hematopoietic stem cells differentiate into common myeloid or lymphoid progenitors. Many innate immune cells originate from the common myeloid progenitor, which subsequently differentiates into the granulocytes (basophils, neutrophils, eosinophils, mast cells), monocytes, and dendritic cell precursors.
During steady-state conditions, granulocytes in the heart are rare. However, following injury, eosinophils, basophils, and mast cells infiltrate the heart. Following myocardial infarction, eosinophils are recruited to the heart in both clinical and experimental models [2, 3]. Genetic depletion of eosinophils in murine models resulted in a reduction of CD206 reparative macrophages (possibly through inter-leukin (IL)-4 signaling) and subsequent adverse remodeling [2, 3], implicating a role for eosinophils conferring protection following myocardial infarction. Opposingly, eosinophils are also associated with heart failure [3]. In a cohort of patients with symptomatic heart failure, Heat2, a long, noncoding RNA, was significantly upregulated [4]. Heat2 is expressed in both eosinophils and basophils and modulates the proliferation, adhesion, invasion, and transmigration of eosinophils and basophils into the heart in the setting of heart failure [4]. Mast cells, another granulocyte, release cytokines (such as tumor necrosis factor (TNF)) that promote myocardial fibrosis and lead to adverse cardiac remodeling after myocardial infarction [5–8]. Genetic depletion of mast cells or mast cell stabilization showed improved outcomes after myocardial injury [9]. Last, neutrophils respond to pro-inflammatory cytokines and chemokines and are recruited to the heart following injury. Heart-resident macrophages can promote recruitment of neutrophils [6]. In summary, the granulocytes are early innate immune response elements that play important roles in the pathogenesis of disease after cardiac injury. They play independent roles as well as integrative roles with other innate immune cells: the monocytes, macrophages, and dendritic cells. We will focus on these three cell populations for the remainder of the chapter.
MONOCYTES
Monocytes are produced in the bone marrow from hematopoietic precursors, most proximally from the common myeloid progenitor [10]. In mice, monocytes can be distinguished on the basis of their expression of Ly6C. Classical monocytes are identified as Ly6chigh CCR2+ CX3CR1low CD62Lhigh cells [10], while non-classical monocytes are defined as Ly6clow CCR2− CX3CR1high CD62Llow cells [11, 12]. Classical (Ly6Chigh) monocytes can differentiate into macrophages or non-classical monocytes via Nr4a1 [13, 14]. In humans, classical monocytes are identified as CD14+CD16− cells, and nonclassical monocytes are defined as CD16+CD14dim cells [15]. Humans also contain intermediate monocytes (CD14+CD16+) that harbor functional and phenotypic characteristics of both classical and non-classical monocyte populations. In steady state, mouse monocytes have a life span of 1–2 days, whereas human classical monocytes live for about 3 days [16].
During an inflammatory response, classical monocytes increase in abundance due to expanded myelopoiesis in the bone marrow and spleen through IL-1 signaling [17, 18]. Monocytes extravasate into the bloodstream through a C-C chemokine receptor 2 (CCR2) dependent mechanism [19]. Blood monocytes infiltrate into the heart and differentiate into macrophages or dendritic cell subtypes on the basis of instructive cues derived from the local microenvironment. The role of non-classical monocytes in response to inflammation is poorly understood. However, they are thought to act as intravascular macrophages, patrolling the vascular endothelium to maintain vascular integrity, and may also activate cells with the vascular wall [12].
MACROPHAGES
Specialized macrophages exist in all tissues (liver: Kupfer cells; lung: alveolar macrophages; brain: microglia; bone: osteoclasts; lymph nodes: histiocytes) and play essential roles in embryonic development, homeostasis, disease, and wound healing [20, 21]. Tissue-resident macrophages perform housekeeping and sentinel activities [22–24]. Macrophages engulf pathogens, foreign bodies, and cell debris through phagocytosis to function as antigen-presenting cells to the adaptive...